EXSCIENTIA LTD has a total of 11 patent applications. Its first patent ever was published in 2019. It filed its patents most often in United Kingdom, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are AKINION PHARMACEUTICALS AB, ALBRECHT BRIAN K and KUDOS PHARM LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 7 | |
#2 | Canada | 1 | |
#3 | EPO (European Patent Office) | 1 | |
#4 | Republic of Korea | 1 | |
#5 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Schreyer Adrian Michael | 4 |
#2 | Bell Andrew Simon | 4 |
#3 | Versluys Stéphanie | 2 |
#4 | Versluys Stephanie | 2 |
Publication | Filing date | Title |
---|---|---|
GB202101703D0 | Drug optimisation by active learning | |
GB202018411D0 | Malt-1 modulators i | |
GB202018412D0 | Malt-1 modulators ii | |
GB202017177D0 | Computational drug target selection | |
GB202016884D0 | Drug optimisation by active learning | |
GB202011362D0 | Antiviral compounds II | |
GB202010586D0 | Antiviral Compounds | |
WO2019233994A1 | Pyrazolopyrimidine compounds as adenosine receptor antagonists |